Core Viewpoint - Aditxt Inc. (NASDAQ:ADTX) shares experienced a significant increase of 52.11% in after-hours trading, reaching $2.16, following the filing of a definitive proxy statement for a special stockholder virtual meeting scheduled for January 30, 2026 [1] Group 1: Shareholder Proposals - The proxy statement includes several key proposals that require shareholder approval, including compliance with Nasdaq Marketplace Rule 5635(d), which mandates shareholder approval for issuances exceeding 20% of outstanding shares at below-market prices [2] - Proposals involve the issuance of common stock related to Series A-1 Convertible Preferred Stock from December 2023, Series C-1 Convertible Preferred Stock and warrants from May and August 2024, and common stock purchase warrants from July 2024 [3] Group 2: Employee Incentives and Stock Split - Aditxt is seeking approval for its 2025 Employee Stock Purchase Plan, allowing employees to buy company stock at a discount through payroll deductions, and an amendment to the 2021 Omnibus Equity Incentive Plan, increasing the number of shares from 3 to 350,000 [3] - The board is requesting discretionary authority to implement a reverse stock split at a ratio between 1-for-5 and 1-for-250, with the specific ratio to be determined by the board within one year of stockholder approval [4] Group 3: Name Change and Advisory Vote - Stockholders will also vote on a non-binding advisory proposal to change the company name from "Aditxt, Inc." to "bitXbio, Inc." [5] - Kingsdale Advisors will act as the strategic stockholder advisor and proxy solicitation agent for the meeting [5] Group 4: Trading Metrics - Year-to-date, ADTX shares have declined by 99.97%, with a current market capitalization of $794,410 [6] - On the previous trading day, Aditxt shares closed down 1.39% at $1.42, and the stock has a negative price trend across all time frames according to Benzinga's Edge Stock Rankings [6]